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Abstract
Patients with rare illnesses may use medication information sources that are appreciably different
from those used by patients with more common illnesses. This article's purpose is to describe
vasculitis patients' most frequently used medication information sources, determine which sources
patients perceive as credible, and explore gender differences in source use and perceived
credibility. Using an online questionnaire, patients (n=232) indicated how often they obtained
medication information from 12 sources during the previous year and rated the credibility of 6
sources. The authors used multivariate analysis of covariance and follow-up contrasts to test for
gender differences in source use and conducted t tests to compare patients' perceived credibility
ratings. Patients used physicians and the Internet most often to obtain medication information and
rated them as the most credible sources. Male patients used their spouse/partner more often and
rated them as more credible than did female patients. Female patients were more likely to use
medication package inserts and the Internet and were less likely to use nurses than were male
patients. There appear to be similarities and differences between the information-seeking
behaviors of vasculitis patients and other patient populations. Because male patients view their
spouse/partner as a credible information source, providers may want to involve the spouse/partner
in prescription decision making.
The availability of medication information has increased dramatically over the past few
decades. This increase is due to a number of factors, including the growth of health-related
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Web sites on the Internet (Cline & Haynes, 2001; Fox & Rainie, 2000), direct-to-consumer
drug advertisements (Khanfar, Loudon, & Sicar-Ramsewak, 2007), policy changes to
improve medication package inserts (Amery, 1999), and increased patient advocacy and
consumerism (Dutta-Bergman, 2005). Given the growing number of information sources,
the variability in quality across sources (Berland et al., 2001; Thompson & Graydon, 2009),
and the relation between information and positive patient outcomes (Rutten, Arora, Bakos,
Aziz, & Rowland, 2005), it is important to understand where patients obtain information
about their medications.
Patients generally obtain health information from multiple sources, although physicians are
generally ranked as one of the most preferred and trusted sources (Hesse et al., 2005; Mayer
et al., 2007; Narhi, 2007; Rutten et al., 2005; Trewin & Veitch, 2003). Even though
physicians are often preferred, they are not necessarily the most frequently used source. For
example, studies have found that patients consulted the Internet (Hesse et al.), information
leaflets (Narhi), and pharmacists (Sleath, Wurst, & Lowery, 2003) more often than
physicians. Other frequently consulted health information sources include books (Hesse et
al.) and newsletters (Huber & Cruz, 2000), nurses (Luker, Beaver, Leinster, & Owens, 1996;
Mills & Davidson, 2002; Rutten et al.), and mass media sources such as newspapers,
magazines, and television (Cunningham, Davidson, Nakazono, & Andersen, 1999; Huber &
Cruz; Narhi; Rutten et al.). Family and friends also are important sources of health
information for patients (Huber & Cruz; Rutten et al.; Sleath et al.).
Many factors, including gender, can affect patients' information-seeking behavior. Female
patients have consistently sought information more frequently and from more sources than
have male patients (Mayer et al., 2007; Rutten et al., 2005; Huber & Cruz, 2000). Additional
factors, including age (Hesse et al., 2005; Narhi, 2007; Rutten et al.; Sleath et al., 2003),
education (Mayer et al.; Rutten et al.), race (Cunningham et al., 1999; Rutten et al.;
Williams, Anstrom, Friedman, & Schulman, 2007), and phase of illness (Rutten et al.) can
also influence patients' information-seeking behavior. To be specific, younger people and
those with higher levels of education tend to seek more information than older people and
those with lower levels of education (Mayer et al.; Rutten et al.), whereas the effect of race
has been inconsistent (Cunningham et al.; Williams et al.). Source preference also varies
with phase of illness; patients prefer written materials in the early stages of their disease,
whereas family and friends become more important sources as the disease progresses
(Rutten et al.).
Most of the aforementioned findings are from samples of cancer patients and assess general
rather than medication-specific information-seeking behaviors. Although not tested
empirically, it is reasonable to assume that information source use is not identical across
different patient groups, especially for patients living with a rare illness. Vasculitis patients
represent one such group; the prevalence of anti-neutrophil cytoplasmic antibodies–
associated granulomatosis vasculitis (Woywodt & Matteson, 2006), the most common form
of vasculitis, is 30 cases/million U.S. citizens (Cotch et al., 1996).
Vasculitis causes blood vessel inflammation and is characterized by an unpredictable course
of relapses and remission. Medications are critical for patient survival because they induce
remission in patients experiencing relapses as well as prevent subsequent relapses once
remission is achieved. Treatment with vasculitis medications improves the 5-year survival
rate between 70 and 90%; however, approximately 20% of patients do not respond to
treatment and 50% of responders will subsequently experience a relapse (Walsh & Jayne,
2007). Patients experiencing a relapse are typically prescribed a combination of
immunosuppressive medications and cytotoxic agents to control inflammation and prevent
organ damage. After achieving remission, many patients are prescribed maintenance therapy
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drugs, such as immunosuppressive medications and antibiotics, which reduce the rate of
subsequent relapses (Puechal, 2007). Sometimes patients stop taking medications
completely after a 6–12-month maintenance period, whereas others have to remain on
maintenance medications for the rest of their lives. Although induction of remission and
additional years of life are major benefits of vasculitis medications, medical treatment also
carries certain burdens, including serious medication side effects, loss of income as a result
of missed days of work, alteration of routine, and constant symptom monitoring (Hoffman et
al., 1998).
Although vasculitis patients may be just as motivated to obtain medication information as
patients with more common illnesses, these patients do not have access to the same types of
information sources. For example, it is unusual to hear vasculitis discussed on television.
Moreover, popular print media sources, such as newspapers and magazines, do not publish
articles about vasculitis with nearly the same frequency as articles about more common
diseases. Partially because of vasculitis' lack of exposure in the media, the general public's
awareness of the disease is low. For this reason, family and friends, which cancer (Rutten et
al., 2005) and HIV patients (Huber & Cruz, 2000) commonly use for disease-related
information, are unlikely to have valuable vasculitis-specific information to share, unless
they search for this information themselves.
Because the medication information sources used by patients with a rare illness may be
appreciably different from other disease groups, the primary goal of this article is to describe
vasculitis patients' most commonly used sources of medication information and determine
which sources patients perceive as most credible. A secondary goal is to investigate whether
there are gender differences in source use and perceived credibility of information sources.
Specifically, patients' use of 12 sources, including physicians, pharmacists, nurses,
brochures and pamphlets, medicine package inserts, articles and books, the Internet,
vasculitis support groups, spouse/ partner, family members, friends, and patient newsletters,
are explored.
Methods
All data were collected as part of the Accessing Social Support in Symptom Treatment
(ASSIST) Study, which assessed the information-seeking behaviors of vasculitis patients.
The ASSIST Study consisted of two online questionnaires administered 3 months apart. To
be eligible for participation, patients must have a self-reported diagnosis of vasculitis, be at
least 18 years of age, be able to read and write in English, have access to the Internet, and
currently be taking at least one vasculitis medication. This study was approved by the
Institutional Review Board at the University of North Carolina at Chapel Hill.
We recruited participants for the ASSIST Study in four ways. We distributed study
brochures at a vasculitis patient conference, which yielded 45 interested patients, 39 of
whom were eligible. In addition, we mailed study announcement letters to known vasculitis
patients (n = 361) who were part of the Glomerular Disease Collaborative Network, which is
a collaboration of the University of North Carolina and community nephrology offices
across the southeastern United States. Of the 67 Glomerular Disease Collaborative Network
patients who returned correspondence, 38 were eligible to participate. For our third
recruitment method, we contacted physician-diagnosed vasculitis patients (n = 124) who
were part of two studies at the Thurston Arthritis Research Center; 29 of the 39 (74%)
patients who responded were eligible and interested. Our final method involved posting
general announcements (including a study podcast) on vasculitis Web sites and in patient
newsletters. Information about the study was also distributed at local support group meetings
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and circulated on eight vasculitis e-mail groups and list-servs; 147 of the 155 patients who
contacted us in response to these general announcements were eligible.
Thus, 306 patients, 253 (83%) of whom were eligible and interested, responded to our
various recruitment efforts. Reasons for ineligibility included not taking vasculitis
medications (n = 25), patient death (n = 9), not having access to the Internet (n = 9), being
too busy to participate (n = 4) and not having a diagnosis of vasculitis (n = 1). An additional
5 patients refused to participate after learning more about the study.
Measures
All study measures described below were completed as part of the ASSIST baseline
questionnaire.
Sociodemographics—Before completing main study measures, participants answered
various demographic and disease-related questions, including one item each about gender,
race, age, education (in years), year of diagnosis, vasculitis type (Wegener's granulomatosis,
microscopic polyangiitis, Churg Strauss syndrome, Takayasu arteritis, other), phase of
illness (currently experiencing relapse/flare vs. not currently experiencing relapse/ flare),
and health insurance status (insured versus not insured). A disease duration variable was
created by subtracting the year in which the patient was diagnosed with vasculitis from the
midpoint of our data collection year (2008.5). In addition, participants indicated whether
they lived within or outside the United States (U.S., international).
Frequency of Medication Source Use—We asked patients how often they obtained
vasculitis medicine information from 12 sources, including physicians, pharmacists, nurses,
brochures and pamphlets, medicine package inserts, articles and books, Internet (information
Web sites), support groups (online or in-person), spouse/partner, family members other than
their spouse, friends, and newsletters. For each source, patients answered one item about
how often they had obtained vasculitis medicine information during the past year, reporting
on a 5-point scale ranging from 1 (never) to 5 (always).
Source Credibility—To limit respondent burden, we focused our assessment of source
credibility on six sources that have influenced patient medication adherence in previous
studies (Gallant, 2003; Meredith, Jeffe, Mundy, & Fraser, 2001; O'Brien, Petrie, & Raeburn,
1992), including the Internet, physicians, pharmacists, spouse/partners, family members/
friends, and other vasculitis patients. Specifically, if patients reported that they had obtained
information about vasculitis medicines from any one of six sources, then they were asked to
rate the perceived credibility of that source. Hence, if patients did not report obtaining
vasculitis medication information from the pharmacist, for example, they did not complete
perceived credibility items about the pharmacist. Credibility was measured by two items that
were derived from the McCroskey and Teven Credibility Scale (McCroskey & Teven,
1999). The first item asked how knowledgeable a source was about vasculitis medicines,
reported on a 9-point scale ranging from 1 (not at all knowledgeable) to 9 (extremely
knowledgeable); the second item asked how expert the source was about vasculitis
medicines, reported on a 9-point scale ranging from 1 (not at all expert) to 9 (extremely
expert). Interitem correlations ranged from .92 for family credibility to .81 for Internet
credibility. A summary score was created for each source by averaging the two items.
Data Analysis—We used SAS (Version 9.2) to generate univariate statistics (means,
standard deviations) to characterize the sample. We then calculated descriptive statistics for
male and female patients on the key study variables (frequency of source use, perceived
credibility). To determine whether there were differences in how often men and women used
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medication information sources during the past year, we ran a multivariate analysis of
covariance model using PROC MIXED to determine whether there was a significant source
by gender interaction. In this analysis, subject (participant) was treated as a random effect
and information source and gender were treated as fixed effects. The 12 frequency-of–
source-use variables were the dependent variables, information source (e.g., physician,
pharmacist, spouse) and patient gender were treated as the primary independent variables
and age, education, race (white vs. nonwhite), participant type (United Sates vs.
international), self-defined vasculitis type, insurance status, phase of illness (relapse vs.
remission) and disease duration were the control variables. If the Source × Gender
interaction term was significant (p < .05), we proceeded by contrasting men and women for
each of the 12 information sources. To contrast men and women, we created a male and
female category for each source, which resulted in 24 different categories. For example,
physician (Source 1) was split into two categories (“g1 s1” and “g2 s1”) in which g1
referred to men, g2 referred to women, and s1 referred to Source 1. This procedure was
repeated for each of the 12 sources; thus, our F tests for contrasts had 2,374 degrees of
freedom and were considered significant if the p value was less than .01.
For our perceived credibility analyses, we used independent sample t-tests to compare men
and women's ratings of six sources: doctors, pharmacists, spouses, family members, other
vasculitis patients, and the Internet. We applied the Bonferroni correction to our results;
thus, individual t-tests were only considered significant if p < .008 (i.e., .05/6).
Results
Sample Characteristics
Twenty-one patients did not complete the baseline questionnaire. Reasons for non-
completion included technical issues (n = 7), being too sick (n = 4) or too busy (n = 3) to
participate, or never responding to study correspondence (n = 7). Thus, 232 of 253 eligible
patients (92%) completed the questionnaire. When compared with completers,
noncompleters were not significantly different in terms of gender or vasculitis type; we did
not have any additional variables with which to compare completers and noncompleters.
Table 1 summarizes the demographic and clinical characteristics of male and female study
participants. A majority of participants were female (69%), White (91%), in a committed
relationship (81%) and had a diagnosis of anti-neutrophil cytoplasmic antibodies–associated
granulomatous vasculitis (59%). On average, participants were middle-aged (M=50.96,
SD=13.51) and reported some college education (M = 15.58, SD = 2.87). Forty-eight (21%)
participants resided outside the United States. Patients had been living with vasculitis for an
average of 6.5 years, and 27.6% were currently experiencing a relapse or flare. Of patients,
94% reported having health insurance. Differences between male and female participants are
noted in Table 1.
Sources of Medication Information
During the past year, physicians were the most frequently used medication information
source for both male and female patients, whereas the Internet was the second most used
source (Figure 1). Patients also obtained medication information from medication package
inserts, but they used other written materials such as books and articles, brochures and
pamphlets, and newsletters less often. Support groups and nonphysician health
professionals, such as nurses and pharmacists, were not used frequently during the past year
by patients. Two of the least used sources were non–health professionals, such as family
members other than the spouse and friends. The spouse/partner was the third most
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frequently used source for men, but the absolute least used source for women. These
differences are subsequently discussed in greater detail.
Gender Differences in Source Use
The Source × Gender interaction term, F(1, 2374) = 12.76, p < .0001, was significant in the
multivariate model, controlling for age, education, race, vasculitis type, international
participant status, health insurance status, time since last relapse/flare, and disease duration.
Besides a main effect for information source, F(1, 2374) = 78.20, p < .0001, there were no
other significant variables in the model. Follow-up contrasts (Table 2) revealed that the
largest gender difference was seen for the spouse/partner, with men using this source more
often than women. Patients also differed in their use of the Internet, with women obtaining
information from this source more often than men. The third largest gender difference in
source use was seen for medication package inserts; women were more likely than men to
obtain information from this source. Alternatively, men were more likely to obtain
medication information from nurses than were women. We did not find any other significant
gender differences in source utilization.
Perceived Credibility of Medication Information Sources
On a scale from 1 to 9, the two most credible sources for both male and female patients were
physicians and the Internet (Figure 2). Although not rated as highly, pharmacists and other
vasculitis patients were perceived as fairly credible information sources. Male patients rated
family members as the least credible source, whereas female patients rated them as the
second least credible source. Similar to our previous finding with the source frequency
variable, there was a discrepancy between males and females in terms of how credible they
viewed their spouse/partner, with men rating their partners as fairly credible, whereas
women rated their partners as the least credible of the six sources.
Gender Differences in Source Credibility
The Bonferroni-corrected t test revealed that the gender difference in spouse/partner
credibility was significant (Table 3). No other significant gender differences in source
credibility were found, although the t test for other vasculitis patients trended toward
significance. In this case, women rated other vasculitis patients as more credible sources
than men did.
Discussion
To our knowledge, this is the first study to describe vasculitis patients' medication
information-seeking behavior. Our results revealed that, in some ways, vasculitis patients
possess source preferences and credibility ratings that are similar to those of other patient
groups. For example, cancer patients, like vasculitis patients, sought information most often
from health care providers and the Internet (Rutten et al., 2005), with physicians rated as
their most trusted information source (Hesse et al., 2005). In addition, vasculitis patients' use
of written materials, such as medication package inserts and books, mirrors that of other
patient populations (Huber & Cruz, 2000; Rutten et al., 2005).
There may also be important differences in the types of sources that vasculitis patients
consult when compared with other patient groups. For example, when compared with HIV
(Huber & Cruz, 2000) and cancer patients (Rutten et al., 2005), vasculitis patients appear to
use support groups more often and family and friends less often. Specifically, patients in our
study ranked support groups as their fourth most frequently used source, whereas family and
friends (other than the spouse) were ranked among the least used sources; other studies have
found that family and friends are used more often than support groups (Huber & Cruz;
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Rutten et al.). That vasculitis is a rare disease could partially explain this finding. Whereas a
high percentage of people living in the United States probably know someone with cancer or
have seen a story about an HIV-positive person, it is unlikely that they know someone living
with vasculitis. In the absence of family and friends who are knowledgeable about the
disease, patients may view vasculitis support groups as more reliable sources of medication
information.
We found that vasculitis patients may underuse nonphysician health professionals such as
nurses and pharmacists for medication information. Even though patients rated pharmacists
as fairly credible information sources, they were only consulted rarely to sometimes during
the past year. Nurses were consulted even less frequently, which makes sense given that
most medical practices and hospitals do not have nurses specifically trained in vasculitis
care. It is unclear whether patients did not use pharmacists and nurses because they obtained
the medication information they needed from other sources, such as physicians and the
Internet, or because there were access issues, whereby it was difficult to contact nurses or
pharmacists. Future studies that are qualitative in nature may help elucidate why vasculitis
patients did not consult nonphysician health professionals often for medication information.
We were surprised by the magnitude of the gender difference in how vasculitis patients view
and use their spouse/partner as an information source. Male patients ranked their spouse/
partner as their third most used and fourth most trusted source of medication information. In
contrast, female patients ranked their spouse/partner as their least used (out of a list of 12
sources) and least credible (out of a list of 6 sources) source of information.
There are several possible explanations for the aforementioned finding. First, women seek
more health information from more sources than men (Huber & Cruz, 2000; Mayer et al.,
2007; Rutten et al., 2005). Hence, for women, the relative credibility of partners may
decrease when compared with information from more objective sources such as pharmacists,
written materials, and the Internet. Alternatively, gender roles and socialization may explain
why male and female patients have dramatically different opinions of their spouse/partner as
a source of medication information. In Western societies, women often take on a nurturing
role, which may make them feel responsible for the health of their family members,
including partners (Gabriel & Gardner, 1999). Hence, women may feel that it is their duty to
research multiple aspects of their partner's disease, including its treatment. Alternatively,
men are socialized to be strong and resistant to illness (Lee & Owens, 2002), which may
make them less likely to seek medical services and information (Verbrugge, 1985). Because
we did not ask participants to report their spouse/partner's gender, we cannot verify that all
spouses of male patients were female. In addition, female participants were younger, more
likely to be international participants, less likely to be married, and had been living with
vasculitis for a shorter amount of time than male patients, although it is unlikely that these
demographic differences were primarily responsible for our findings.
Medication package inserts, the Internet, and nurses represent three other sources that men
and women used differently. Women consulted package inserts and the Internet more often
than men did, whereas men were more likely than women to consult nurses. Again, we
believe the fact that women search for information from more sources than men may explain
why they used package inserts and the Internet more frequently. However, we do not have
an explanation for why men seek health information from nurses more frequently than
women. To reduce respondent burden, we did not ask participants to rate the perceived
credibility of all 12 sources. It could be that men believe nurses are more credible sources of
information than women do; thus, they consult them more often. Future studies should ask
participants to rate the credibility of all sources to determine whether credibility is the
driving force behind gender differences in source use.
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None of the demographic and clinical variables that we included in our multivariate model
had a significant effect on how often patients' consulted different information sources. The
relative homogeneity of vasculitis samples (predominately White, middle-aged and well-
educated) make it difficult to assess the effect of these potential moderating variables. Also,
because we did not have many international participants (n = 48), we did not have sufficient
power to detect inter-country differences in information seeking. Although phase of illness
has been associated with information seeking in previous research (Rutten et al., 2005), our
disease status variable was not a significant predictor in our sample.
Because we used an online survey to collect data, the results of our study, especially
findings regarding the Internet, should not be generalized to the greater vasculitis
population. It is likely that non–Internet users have markedly different opinions about the
credibility of Internet sources. Researchers who are interested in non–Internet-using patients
could use pen-and-paper surveys or telephone interviews to capture the information source
preferences of this group. Our low response rate to our mailed recruitment efforts further
limits our ability to generalize the study findings.
The baseline questionnaire asked participants to report their medication information source
use during the past year. This retrospective examination of information seeking is a
limitation of our study that is subject to recall bias. Longitudinal studies that examine
patients' information-seeking behavior over the course of their illness are a logical next step,
particularly because source use has been shown to change over time (Mills & Davidson,
2002; Rutten et al., 2005; Squiers, Rutten, Treiman, Bright, & Hesse, 2005). Moreover, our
assertion that vasculitis patients differ from other patient groups is speculative at this point,
especially because we are comparing results that are specific to medication information to
more general studies of health information seeking. Additional research should recruit
samples of patients with different diseases to determine whether disease type truly
influences information source use and preference. A comparison of a common disease, such
as arthritis or diabetes, with a rare disease, such as vasculitis, may be particularly
enlightening.
Conclusions
As with other patient populations, vasculitis patients consult multiple sources for medication
information. The number of sources that patients consult may be more limited when
compared to a disease such as cancer, which makes the information provided by the
physician particularly valuable to patients. In the eyes of patients, physicians are their most
credible source of medication information. However, patients also rated the Internet as a
very credible source. Because medication information on the Internet is not necessarily
accurate or presented in a patient-friendly manner (Thompson & Graydon, 2009), physicians
may want to direct their vasculitis patients to high-quality Web sites. Moreover, because the
social networks of vasculitis patients are likely to be devoid of family and friends who are
knowledgeable about vasculitis, physicians should consider referring patients to
organizations such as the Vasculitis Foundation, which can help guide patients to online and
local support groups.
Because male patients think of their spouse/partner as a trusted source of medication
information, physicians should attempt to include male patients' partners in the disease-
management process. Previous studies have found that partners undergo a pattern of
information seeking that is comparable, if not more thorough, than that of the patient (Echlin
& Rees, 2002). For this reason, it is particularly important that physicians and other health
care professionals equip patients and their partners with accurate medication information.
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Frequency of medication information source use for male and female vasculitis patients
during the past year (n = 232). Responses were reported on a 5-point scale ranging from 1
(never) to 5 (always).
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Perceived credibility ratings of six medication information sources for male and female
vasculitis patients (n=232). Responses were reported on a 9-point scale ranging from 1 (not
at all expert/knowledgeable) to 9 (extremely expert/knowledgeable).
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Table 1
Sample characteristics for male and female vasculitis patients (n = 232)
M ± SD or %
Characteristic Male (n=71) Female (n=161) Range
Age 54.75 ± 12.11 49.29 ±13.79 21.0–82.0 years
White 95.77% 88.83%
Education 4.0–22.0 years
 High school or less 18.60% 18.83%
 Some college 15.72% 18.63%
 College graduate or more 65.71% 57.89%
International participant 9.86% 25.80%
In committed relationship 88.73% 77.64%
Disease type
 Wegener's granulomatosis 71.83% 54.04%
 Churg-Strauss syndrome 11.27% 13.04%
 Microscopic polyangiitis 7.04% 8.07%
 Takayasu arteritis 0.00% 7.45%
 Other 9.86% 17.39%
Years with disease 8.06 ± 6.60 5.77 ± 5.81 0.5–36.5 years
Health insurance 95.77% 92.45%
Currently relapsing 22.54% 27.81%
Note. On the basis of the results of independent samples t tests (p < .05), female participants were younger, more likely to be international
participants, less likely to be married, less likely to have Wegener's granulomatosis, and had lived with vasculitis for fewer years than male
patients.
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Table 2
Analysis of covariance results contrasting male and female vasculitis patients' frequency
of source use for 12 different medication information sources during the past year
M ± SD
Source Male (n = 71) Female (n = 159) F p
Spouse/partner 3.11 ± 1.9 1.62 ± 1.1 70.73 <.0001*
Internet 3.27 ±1.2 3.84± 1.1 12.39 <.001*
Package inserts 2.94 ±1.2 3.52± 1.3 11.70 <.001*
Nurses 2.65 ±1.2 2.14± 1.1 7.67 <.01*
Support groups 2.67 ±1.3 3.05 ± 1.3 4.33 .04*
Brochures 2.57 ±1.0 2.87 ± 1.2 3.31 .07
Books and articles 2.67 ±1.0 2.92 ± 1.2 2.82 .09
Pharmacist 2.61 ±1.3 2.78 ± 1.4 2.37 .12
Friends 1.49 ±0.7 1.64 ±0.9 1.04 .31
Physician 4.20 ±0.9 4.01 ± 1.1 0.69 .41
Newsletters 2.55 ±1.2 2.59 ± 1.3 0.35 .55
Family members 1.76±1.1 1.75 ± 1.0 0.22 .58
Note. Frequency of source use responses reported on a 5-point scale ranging from 1 (never) to 5 (always). None of the control variables, including
age, education, race, vasculitis type, international participant status, health insurance status, time since last relapse/flare, and disease duration, was
significant.
*
Significant F value, p < .05.
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